Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Loading NPHC News...
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||-0.80%||69.29||1.0%||$931.38m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.12%||371.61||1.9%||$348.38m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.83%||129.89||2.0%||$299.57m|
|VRTX||Vertex Pharmaceuticals Incorporated||-2.02%||86.55||2.6%||$140.07m|
|CLVS||Clovis Oncology, Inc.||-4.27%||62.99||16.4%||$132.37m|
|A||Agilent Technologies, Inc.||-0.54%||51.35||1.7%||$117.26m|
|ACAD||ACADIA Pharmaceuticals Inc.||-0.20%||39.20||19.0%||$93.83m|
|BMRN||BioMarin Pharmaceutical Inc.||0.41%||90.24||4.0%||$89.98m|
Nutra Pharma Corp. is a biopharmaceutical company, which is engaged in the acquisition, licensing and commercialization of pharmaceutical products and technologies and homeopathic and ethical drugs for the management of pain, neurological disorders, autoimmune and infectious diseases. Its products are Cobroxin, which is used for an over-the-counter pain reliever designed to treat moderate to severe chronic pain and Nyloxin Extra Strength, which is used for stronger versions of Cobroxin. The company was founded on February 1, 2000 and is headquartered in Coral Springs, FL.